In this study, the expression of CAIX in xenografted tumors of NPC was significantly downregulated when treated with DOX-NB + DUS group compared with DOX + DUS group or DOX-NB group, as determined using immunohistochemical staining. The gene discussed is CA9; the disease is nasopharyngeal carcinoma.